Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL236625 | 1.00 | TSHR (0.30) | TSHRTHPO | |
| SCHEMBL236626 | 1.00 | TSHR (0.30) | TSHRTHPO | |
| SCHEMBL13039773 | 0.71 | — | — | |
| SCHEMBL12975431 | 0.71 | TSHR (0.38) | TSHRTHPO | |
| SCHEMBL12336186 | 0.71 | — | — | |
| SCHEMBL7587650 | 0.71 | — | — | |
| SCHEMBL17718261 | 0.70 | — | — | |
| SCHEMBL1782037 | 0.69 | TP53 (0.42) | TSHRTHPO | |
| SCHEMBL1782034 | 0.69 | TP53 (0.42) | TSHRTHPO | |
| SCHEMBL18503669 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 368 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12589377-B2 | Encapsulated composition comprising core-shell microcapsules and process for its preparation | GIVAUDAN SA (CH) | 2026-03-31 | — | — | US | claimed |
| US-12559703-B2 | Fragrance composition | GIVAUDAN SA (CH) | 2026-02-24 | — | — | US | claimed |
| EP-4655373-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2025-12-03 | — | — | EP | claimed |
| WO-2024156688-A1 | BIODEGRADABLE PERFUME COMPOSITION | GIVAUDAN SA (CH) | 2024-08-02 | — | — | WO | claimed |
| EP-4407019-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2024-07-31 | — | — | EP | claimed |
| US-20240239994-A1 | COMPOSITIONS TO LIMIT, REDUCE OR ELIMINATE MALODOURS ASSOCIATED WITH PLASTIC MATERIALS | FIRMENICH SA (CH) | 2024-07-18 | — | — | US | claimed |
| US-20240197243-A1 | FRAGRANCE FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2024-06-20 | — | — | US | claimed |
| EP-4347757-A1 | FRAGRANCE FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING | Givaudan SA (CH) | 2024-04-10 | — | — | EP | claimed |
| US-11938242-B2 | Apparatus and method for reducing malodor on surfaces | THE PROCTER & GAMBLE PLAZA (US) | 2024-03-26 | — | — | US | claimed |
| EP-4319716-A1 | COMPOSITIONS TO LIMIT, REDUCE OR ELIMINATE MALODOURS ASSOCIATED WITH PLASTIC MATERIALS | Firmenich SA (CH) | 2024-02-14 | — | — | EP | claimed |
| US-6727221-B1 | APPLYING TO HUMAN SKIN A PERFUME COMPOSITION COMPRISING AT LEAST 50% BY WEIGHT OF PERFUME COMPONENTS HAVING A MINIMUM INHIBITORY CONCENTRATION (MIC) FOR CORYNEFORM BACTERIA OF GREATER THAN 0.1% | QUEST INTERNATIONAL B.V. (NL) | 2004-04-27 | — | — | US | claimed |
| EP-1094784-B1 | PERFUME COMPOSITION | QUEST INT (NL) | 2004-02-11 | — | — | EP | claimed |
| EP-1093357-B1 | METHOD OF REDUCING OR PREVENTING MALODOUR | QUEST INT (NL) | 2004-01-07 | — | — | EP | claimed |
| US-6540988-B1 | Topically applying a perfume component which is capable of inhibiting bacterial 4-ene reductase and/or 5-alpha-reductase to inhibit production of odoriferous steroids by microorganisms | QUEST INTERNATIONAL B.V. (NL) | 2003-04-01 | — | — | US | claimed |
| EP-1094784-A1 | PERFUME COMPOSITION | QUEST INTERNATIONAL B.V. (NL) | 2001-05-02 | — | — | EP | claimed |
| EP-1093357-A1 | METHOD OF REDUCING OR PREVENTING MALODOUR | QUEST INTERNATIONAL B.V. (NL) | 2001-04-25 | — | — | EP | claimed |
| EP-1093355-A1 | METHOD OF REDUCING OR PREVENTING MALODOUR | QUEST INTERNATIONAL B.V. (NL) | 2001-04-25 | — | — | EP | claimed |
| WO-2000001358-A1 | METHOD OF REDUCING OR PREVENTING MALODOUR | QUEST INTERNATIONAL B.V. (NL) | 2000-01-13 | — | — | WO | claimed |
| WO-2000001352-A1 | PERFUME COMPOSITION | QUEST INTERNATIONAL B.V. (NL) | 2000-01-13 | — | — | WO | claimed |
| WO-2000001356-A1 | METHOD OF REDUCING OR PREVENTING MALODOUR | QUEST INTERNATIONAL B.V. (NL) | 2000-01-13 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11938242-B2 | Apparatus and method for reducing malodor on surfaces | AOX1, AOC2, AOC1 | TSHR 2457/4885THPO 4249/4885 |
| US-12589377-B2 | Encapsulated composition comprising core-shell microcapsules and process for its preparation | CUTA, EXOC1, EXOSC10 | TSHR 2858/4885THPO 2292/4885 |
| US-12559703-B2 | Fragrance composition | DHCR24, OPRD1, OR10J3 | TSHR 3559/4885THPO 3641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.